Clinical Trial Update: Regulatory T Cells for Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 trial by Cellenkos evaluating regulatory T cells for amyotrophic lateral sclerosis is active but not recruiting. It represents an early-stage explorat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Regulatory T Cells (regulatory T cells)

Snippet

Sponsor: Cellenkos, Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING